![Is preexisting immunity to seasonal coronaviruses limited to cross-reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France - eBioMedicine Is preexisting immunity to seasonal coronaviruses limited to cross-reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France - eBioMedicine](https://www.thelancet.com/cms/attachment/86769381-94ba-420c-91c9-6c2bb6aa8800/gr1_lrg.jpg)
Is preexisting immunity to seasonal coronaviruses limited to cross-reactivity with SARS-CoV-2? A seroprevalence cross-sectional study in north-eastern France - eBioMedicine
![Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross](https://www.thelancet.com/cms/attachment/b91ec0fd-8012-4891-97bb-4ca05b396d3a/gr1_lrg.jpg)
Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant sublineages BA.2 and BA.5 among older adults with comorbidities: a cross
![Is measuring immunity to SARS-CoV-2 is key for understanding COVID-19 and vaccine development? | BioVendor R&D Is measuring immunity to SARS-CoV-2 is key for understanding COVID-19 and vaccine development? | BioVendor R&D](https://www.biovendor.com/file/13864/1.jpg)
Is measuring immunity to SARS-CoV-2 is key for understanding COVID-19 and vaccine development? | BioVendor R&D
![Robust induction of TRMs by combinatorial nanoshells confers cross-strain sterilizing immunity against lethal influenza viruses: Molecular Therapy - Methods & Clinical Development Robust induction of TRMs by combinatorial nanoshells confers cross-strain sterilizing immunity against lethal influenza viruses: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/ca842ac2-c776-40a6-a7f5-7bb083b06c91/fx1_lrg.jpg)
Robust induction of TRMs by combinatorial nanoshells confers cross-strain sterilizing immunity against lethal influenza viruses: Molecular Therapy - Methods & Clinical Development
![Evidence that cross-reactive immunity from common human coronaviruses can influence response to SARS-CoV-2 Evidence that cross-reactive immunity from common human coronaviruses can influence response to SARS-CoV-2](https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_740243_16776450986098691.jpg)
Evidence that cross-reactive immunity from common human coronaviruses can influence response to SARS-CoV-2
![Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial - The Lancet Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/aee18a25-2db9-4bae-83e7-34231c19f7e4/gr1_lrg.gif)
Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial - The Lancet
![The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41577-022-00809-x/MediaObjects/41577_2022_809_Fig1_HTML.png)
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses | Nature Reviews Immunology
![Cross-immune tolerance: conception and its potential significance on transplantation tolerance | Cellular & Molecular Immunology Cross-immune tolerance: conception and its potential significance on transplantation tolerance | Cellular & Molecular Immunology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fcmi.2009.101/MediaObjects/41423_2010_Article_BFcmi2009101_Fig3_HTML.jpg)
Cross-immune tolerance: conception and its potential significance on transplantation tolerance | Cellular & Molecular Immunology
![COVID-19 Q&A #2 - Antibody-Dependent Enhancement, Cross-Immunity, Immunity Duration & More - YouTube COVID-19 Q&A #2 - Antibody-Dependent Enhancement, Cross-Immunity, Immunity Duration & More - YouTube](https://i.ytimg.com/vi/yRlOJRxNZe0/maxresdefault.jpg)
COVID-19 Q&A #2 - Antibody-Dependent Enhancement, Cross-Immunity, Immunity Duration & More - YouTube
![BCG vaccination induces cross-protective immunity against pathogenic microorganisms: Trends in Immunology BCG vaccination induces cross-protective immunity against pathogenic microorganisms: Trends in Immunology](https://www.cell.com/cms/attachment/ea62a8f6-dbe9-468c-baae-2848f30a4085/gr1_lrg.jpg)
BCG vaccination induces cross-protective immunity against pathogenic microorganisms: Trends in Immunology
![Polycationic HA/CpG Nanoparticles Induce Cross-Protective Influenza Immunity in Mice | ACS Applied Materials & Interfaces Polycationic HA/CpG Nanoparticles Induce Cross-Protective Influenza Immunity in Mice | ACS Applied Materials & Interfaces](https://pubs.acs.org/cms/10.1021/acsami.1c19192/asset/images/medium/am1c19192_0001.gif)
Polycationic HA/CpG Nanoparticles Induce Cross-Protective Influenza Immunity in Mice | ACS Applied Materials & Interfaces
![Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans - ScienceDirect Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0092867419301047-fx1.jpg)
Human Anti-fungal Th17 Immunity and Pathology Rely on Cross-Reactivity against Candida albicans - ScienceDirect
Cellular and Humoral Cross-Immunity against Two H3N2v Influenza Strains in Presumably Unexposed Healthy and HIV-Infected Subjects | PLOS ONE
![Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens - ScienceDirect Protective heterologous T cell immunity in COVID-19 induced by the trivalent MMR and Tdap vaccine antigens - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2666634021002890-fx1.jpg)